Corcept Therapeutics (CORT) – Analyst Ratings
-
Truist Securities Upgrades Corcept Therapeutics (CORT) to Buy
-
SVB Leerink Starts Corcept Therapeutics (CORT) at Market Perform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CORT Stock Lookup